Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe

Journal of Virology

Volumn 71, Issue 7, 1997, Pages 5441-5448

  Shafer, Robert W ^a,b   Eisen, Jonathan A ^b   Merigan, Thomas C ^a   Katzenstein, David A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONSENSUS SEQUENCE; DRUG SENSITIVITY; ENVELOPE GENE; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROCONVERSION; VIRUS ISOLATION; ZIMBABWE;

EID: 0030920241     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.7.5441-5448.1997     Document Type: Article

References (52)

1. Bachmann, M. H., E. L. Delwart, E. G. Shpaer, P. Lingenfelter, R. Singal, J. I. Mullins, and WHO Network for HIV Isolation and Characterization. 1994. Rapid genetic characterization of HIV type 1 strains from four world health organization-sponsored vaccine evaluation sites using a heteroduplex mobility assay. AIDS Res. Hum. Retroviruses 10:1345-1353.
2. Balfe, P., P. Simmonds, C. A. Ludlum, J. O. Bishop, and A. J. Leigh Brown. 1990. Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations. J. Virol. 64:6221-6231.
3. Brodine, S. K., J. R. Mascola, P. J. Weiss, S. I. Ito, K. R. Porter, A. W. Artenstein, F. C. Garland, F. E. McCutchan, and D. S. Burke. 1995. Detection of diverse HIV-1 genetic subtypes in the United States. Lancet 346: 1198-1199.
4. Carr, J. K., M. O. Salminen, C. Koch, D. Gotte, A. W. Artenstein, P. A. Hegerich, D. St. Louis, D. S. Burke, and F. E. McCutchan. 1996. Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J. Virol. 70:5935-5943.
5. Coffin, J. M. 1992. Genetic diversity and evolution of retroviruses. Curr. Top. Microbiol. Immunol. 176:143-164.
6. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
7. Cox, S. W., K. Aperia, J. Albert, and B. Wahren. 1994. Comparison of the sensitivities of HIV type 2 and HIV type 1 to antiviral drugs and drug combinations. AIDS Res. Hum. Retroviruses 10:1725-1729.
8. Delwart, E. L., E. G. Shpaer, J. Louwagie, F. E. McCutchan, M. Grez, H. Rubsamen-Waigmann, and J. I. Mullins. 1993. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 262:1257-1261.
9. Delwart, E. L., B. Herring, G. H. Learn, A. G. Rodrigo, and J. I. Mullins. 1996. Heteroduplex mobility analysis HIV-1 env subtyping kit. Protocol version 3. NIH AIDS Research and Reference Reagent Program, National Institutes of Health, Bethesda, Md.
10. Felsenstein, J. 1993. PHYLIP (phylogeny inference package) version 3.5. University of Washington, Seattle.
11. Fransen, K., A. Buve, J. N. Nkengasong, M. Laga, and G. van der Groen. 1996. Longstanding presence in Belgians of multiple non-B HIV-1 subtypes. Lancet 347:1043. (Letter.)
12. Gao, F., D. L. Robertson, S. G. Morrison, H. Hui, S. Craig, P. M. Fultz, J. Decker, M. Girard, G. M. Shaw, B. H. Hahn, and P. M. Sharp. 1996. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J. Virol. 70:7013-7029.
13. Genetics Computer Group, Inc. 1994. Wisconsin package, version 8.1. Genetics Computer Group, Inc., Madison, Wis.
14. Grankvist, O., A. Gustaffson, U. Bredberg-Raden, K. Pallangyo, F. Mhalu, P. Biberfeld, and G. Wadell. 1991. Selection of primers of optimal sensitivity for the detection of HIV-1 from Africa and Europe by the polymerase chain reaction. AIDS 5:575-578.
15. Hillis, D. M., and J. J. Bull. 1993. An empirical test of bootstrapping as a method for assessing confidence in phylogenetic analysis. Syst. Biol. 42:182-192.
16. Hu, D. J., T. J. Dondero, M. A. Rayfield, J. R. George, G. Schochetman, H. W. Jaffe, C.-C. Luo, M. L. Kalish, B. G. Weniger, C.-P. Pau, C. A. Schable, and J. W. Curran. 1996. The emerging genetic diversity of HIV: the importance of global surveillance for diagnostics, research, and prevention. JAMA 275:210-216.
17. Iversen, A. K. N., R. W. Shafer, K. Wehrly, M. A. Winters, J. I. Mullins, B. Chesebro, and T. C. Merigan. 1996. Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy. J. Virol. 70:1086-1090.
18. Keulen, W., C. Boucher, and B. Berkhout. 1996. Nucleotide substitution patterns can predict the requirements for drug-resistance of HIV-1 proteins. Antiviral Res. 31:45-57.
19. Kimura, M. 1980. A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16:111-120.
20. Kumar, S., K. Tamura, and M. Nei. 1993. MEGA: molecular evolutionary genetic analysis, version 1.0. The Pennsylvania State University, University Park.
21. Lalvani, A., and J. S. Shastri. 1996. HIV epidemic in India: opportunity to learn from the past. Lancet 347:1349-1350. (Editorial.)
22. Lasky, M., J.-L. Perret, M. Peeters, F. Bibollet-Ruche, F. Liegeois, D. Patrel, S. Molinier, C. Gras, and E. Delaporte. 1997. Presence of multiple non-B subtypes and divergent subtype B strains of HIV-1 in individuals infected after overseas deployment. AIDS 11:43-51.
23. Leitner, T., D. Escanilla, S. Marquina, J. Wahlberg, C. Brostrom, H. B. Hansson, M. Uhlen, and J. Albert. 1995. Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden. Virology 209:136-146.
24. Li, W.-H., M. Tanimura, and P. M. Sharp. 1988. Rates and dates of divergence between AIDS virus nucleotide sequences. Mol. Biol. Evol. 5:313-330.
25. Louwagie, J., F. E. McCutchan, M. Peeters, T. P. Brennan, E. Sanders-Buell, G. A. Eddy, G. van der Groen, K. Fransen, G.-D. Gershy-Damet, R. Deleys, and D. S. Burke. 1993. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 7:769-780.
26. Mansergh, G., A. C. Haddix, R. W. Steketee, P. I. Nieburg, D. J. Hu, R. J. Simmomls, and M. Rogers. 1996. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African developing country setting. JAMA 276:139-145.
27. Mansky, L. M., and H. M. Temin. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69:5087-5094.
28. Mbizvo, M. T., R. Machekano, W. McFarland, S. Ray, M. Bassett, A. Latif, and D. Katzenstein. 1996. HIV seroincidence and correlates of seroconversion in a cohort of male factory workers in Harare, Zimbabwe. AIDS 10: 895-901.
29. McClure, M. A., M. S. Johnson, D.-E. Feng, and R. F. Doolittle. 1988. Sequence comparisons of retroviral proteins: relative rates of change and general phylogeny. Proc. Natl. Acad. Sci. USA 85:2469-2473.
30. McCutchan, F. E., M. O. Salminen, J. K. Carr, and D. S. Burke. 1996. HIV-1 genetic diversity. AIDS 10(Suppl. 3):S13-S20.
31. Myers, G. 1994. HIV: between past and future. AIDS Res. Hum. Retroviruses 10:1317-1324.
32. Myers, G., and B. Korber. 1994. The future of human immunodeficiency virus, p. 211-232. In S. S. Morse (ed.), The evolutionary biology of viruses. Raven Press, Inc., New York, N.Y.
33. Myers, G., B. Korber, S. Wain-Hobson, R. Smith, and G. N. Pavlakis. 1995. Human retroviruses and AIDS: a compilation and analysis of nucleic and amino acid sequences. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, N.Mex.
34. Nei, M., and T. Gojobori. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3:418-426.
35. Olson, G. J., H. Matsuda, R. Hagstrom, and R. Overbeek. 1994. fastDNAml: a tool for construction of phylogenetic trees of DNA sequences using maximum likelihood. Comput. Appl. Biosci. 10:41-48.
36. Pauwels, R., K. Andries, J. Desmyter, D. Schols, M. Kukla, H. Breslin, A. Raeymaeckers, J. Van Gelder, R. Woestenborghs, J. Heykants, K. Schellekans, M. Janssen, E. De Clercq, and P. Jannsen. 1990. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature 343:470-474.
37. Quinones-Mateu, M. E., A. Holguin, J. Dopazo, I. Najera, and E. Domingo. 1996. Point mutation frequencies in the pol gene of human immunodeficiency virus type 1 are two-to threefold lower than those of env. AIDS Res. Hum. Retroviruses 12:1117-1128.
38. Respass, R., A. Butcher, H. Wang, T. Chaowanachan, N. Young, N. Shaffer, T. Mastro, B. Biryahwaho, R. Downing, A. Tanuri, M. Schecter, R. Pascy, L. Zekeng, L. Kaptue, L. Gurtler, D. Ellenberg, C. Fridland, M. Rayfield, and S. Kwok. 1996. Detection of HIV-1 group M and O virus by PCR, abstr. Th.A.4037. In Abstracts of the XI International Conference on AIDS, Vancouver, British Columbia, Canada.
39. Richman, D. D. 1987. Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1. Antimicrob. Agents Chemother. 31:1879-1881.
40. Rodrigo, A. G., and J. I. Mullins. 1996. Human immunodeficiency virus type 1 molecular evolution and the measure of selection. AIDS Res. Hum. Retroviruses 12:1681-1685.
41. Salminen, M. O., B. Johansson, A. Sonnerborg, S. Ayehunie, D. Gotte, P. Leinikki, D. S. Burke, and F. E. McCutchan. 1996. Full-length sequence of an Ethiopian human immunodeficiency type 1 (HIV-1) isolate of genetic subtype C. AIDS Res. Hum. Retroviruses 12:1329-1339.
42. Seibert, S. A., C. Y. Howell, M. K. Hughes, and A. L. Hughes. 1995. Natural selection on the gag, pol, and env genes of human immunodeficiency virus 1 (HIV-1). Mol. Biol. Evol. 12:803-813.
43. Seillier-Moiseiwitsch, F., B. H. Margolin, and R. Swanstrom. 1994. Genetic variability of the human immunodeficiency virus: statistical and biological issues. Annu. Rev. Genet. 28:559-596.
44. Shafer, R. W., M. J. Kozal, D. A. Katzenstein, W. H. Lipil, I. F. Johnstone, and T. C. Merigan. 1993. Zidovudine susceptibility testing of human immunodeficiency virus type 1 (HIV) clinical isolates. J. Virol. Methods 41:297-310.
45. Shafer, R. W., M. A. Winters, A. K. N. Iversen, and T. C. Merigan. 1996. Genotypic and phenotypic changes during culture of a multinucleoside-resistant human immunodeficiency virus type 1 strain in the presence and absence of additional reverse transcriptase inhibitors. Antimicrob. Agents Chemother. 40:2887-2890.
46. Sharp, P. M., D. L. Robertson, F. Gao, and B. H. Hahn. 1994. Origins and diversity of human immunodeficiency viruses. AIDS 8:S27-S42.
47. Soto-Ramirez, L. E., S. Tripathy, B. Renjifo, and M. Essex. 1996. HIV-1 pol sequences from India fit distinct subtype pattern. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 13:299-307.
48. Subbarao, S., and G. Schochetman. 1996. Genetic variability of HIV-1, AIDS 10(Suppl. A):S13-S23.
49. Vandamme, A.-M., K. Fransen, L. Debaisieux, D. Marissens, S. Sprecher, D. Vaira, A. T. Vandenbroucke, C. Verhofstede, and the Belgian AIDS Reference Laboratories. 1995. Standardization of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harboring strains of diverse geographic origin. J. Virol. Methods 51:305-316.
50. Vartanian, J.-P., A. Meyerhans, B. Åsjö, and S. Wain-Hobson. 1991. Selection, recombination, and G→A hypermutation of human immunodeficiency virus type 1 genomes. J. Virol. 65:1779-1788.
51. Williams, K. J., and L. A. Loeb. 1992. Retroviral reverse transcriptases: error frequencies and mutagenesis. Curr. Top. Microbiol. Immunol. 176:165-180.
52. Wolinsky, S. M., B. T. M. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, J. T. Safrit, and R. A. Koup. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537-542.